Skip to main content

Table 2 Changes of echocardiographic indices before and after RAP

From: Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing

 

LAD (mm)

LAVmax (ml)

LAVmin (ml)

LAEF (%)

LVESD (mm)

LVEDD(mm)

LVEF (%)

Sham group

       

 Baseline

9.73 ± 0.69

0.54 ± 0.08

0.27 ± 0.05

48.82 ± 4.48

8.46 ± 0.99

13.68 ± 1.77

72.20 ± 3.65

 4 weeks post-operation

9.85 ± 0.61

0.53 ± 0.07

0.28 ± 0.05

47.59 ± 6.05

8.44 ± 0.91

13.53 ± 1.53

71.75 ± 2.81

Control group

       

 Baseline

9.58 ± 0.62

0.52 ± 0.09

0.26 ± 0.03

49.42 ± 3.39

8.39 ± 0.88

13.37 ± 1.23

71.18 ± 4.46

 3 weeks after RAP

16.02 ± 0.84*, **

1.94 ± 0.28*, **

1.40 ± 0.18*, **

27.77 ± 4.18*, **

8.77 ± 0.64

13.35 ± 1.28

67.47 ± 2.92

Atorvastatin group

       

 Baseline

9.75 ± 0.56

0.55 ± 0.10

0.28 ± 0.05

49.31 ± 5.48

8.37 ± 0.94

13.58 ± 1.32

71.42 ± 3.15

 3 weeks after RAP

15.53 ± 0.62*, **

1.78 ± 0.24*, **

1.29 ± 0.17*, **

27.32 ± 3.70*, **

8.78 ± 0.78

13.64 ± 1.22

68.50 ± 5.34

  1. Data are reported as mean ± standard deviation
  2. RAP rapid atrial pacing, LAD left atrial diameter, LAV max left atrial maximal volume, LAV min left atrial minimal volume, LAEF left atrial ejection fraction, LVESD left ventricular end systolic diameter, LVEDD left ventricular end diastolic diameter, LVEF left ventricular ejection fraction
  3. *P < 0.05 vs. baseline
  4. **P < 0.05 vs. sham group